blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1457488

EP1457488 - Intermediates for use in the preparation of urea compounds having muscarinic receptor antagonist activity [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.06.2010
Database last updated on 24.08.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
Theravance, Inc.
901 Gateway Boulevard
South San Francisco, CA 94080 / US
[2004/38]
Inventor(s)01 / Mammen, Mathai
5 Barcelona Circle
Redwood Shores California 94065 / US
02 / Oare, David
1622 Ralston Avenue
Belmont California 94002 / US
 [2004/38]
Representative(s)Office Freylinger
P.O. Box 48
8001 Strassen / LU
[2009/27]
Former [2007/40]Kihn, Pierre Emile Joseph, et al
Office Ernest T. Freylinger S.A. & Martin A. Hay 234, route d'Arlon B.P. 48
8001 Strassen / LU
Former [2007/34]Hay, Martin Alexander, et al
Martin A. HAY & OFFICE ERNEST T.FREYLINGER S.A. White Cottage, 33 Castle Hill Prestbury
Cheshire SK10 4AS / GB
Former [2004/38]Hay, Martin Alexander
Martin A. Hay & Co. 13 Queen Victoria Street
Macclesfield Cheshire SK11 6LP / GB
Application number, filing date04012859.707.12.2000
[2004/38]
Priority number, dateUS1999045617007.12.1999         Original published format: US 456170
[2004/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1457488
Date:15.09.2004
Language:EN
[2004/38]
Type: B1 Patent specification 
No.:EP1457488
Date:12.08.2009
Language:EN
[2009/33]
Search report(s)(Supplementary) European search report - dispatched on:EP19.07.2004
ClassificationIPC:C07D211/58
[2004/38]
CPC:
C07D401/06 (EP,KR,US); A61P1/00 (EP); A61P1/02 (EP);
A61P1/04 (EP); A61P11/00 (EP); A61P11/06 (EP);
A61P13/02 (EP); A61P13/10 (EP); A61P25/00 (EP);
A61P25/08 (EP); A61P25/28 (EP); A61P27/02 (EP);
A61P43/00 (EP); C07D211/48 (EP,KR,US); C07D211/52 (EP,KR,US);
C07D401/12 (EP,KR,US); C07D401/14 (EP,KR,US); C07D405/12 (EP,KR,US);
C07D409/12 (EP,KR,US); C07D413/06 (EP,KR,US); C07D471/08 (EP,KR,US);
C07D471/10 (EP,KR,US); C07D471/14 (EP,KR,US); C07D495/08 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2009/33]
Former [2004/38]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
TitleGerman:Zwischenprodukte für die Herstellung von Harnstoffderivaten mit Muskarinrezeptor-antagonistischer Aktivität[2004/38]
English:Intermediates for use in the preparation of urea compounds having muscarinic receptor antagonist activity[2004/38]
French:Produits intermédiaires pour la préparation de dérivés de l'urées présentant une activité antagoniste du recepteur muscarinique[2004/38]
Examination procedure21.10.2004Examination requested  [2004/52]
02.03.2009Communication of intention to grant the patent
22.06.2009Fee for grant paid
22.06.2009Fee for publishing/printing paid
Parent application(s)   TooltipEP00982493.9  / EP1235803
Opposition(s)17.05.2010No opposition filed within time limit [2010/29]
Fees paidRenewal fee
01.06.2004Renewal fee patent year 03
01.06.2004Renewal fee patent year 04
23.12.2004Renewal fee patent year 05
27.12.2005Renewal fee patent year 06
27.12.2006Renewal fee patent year 07
24.12.2007Renewal fee patent year 08
24.12.2008Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT12.08.2009
CY12.08.2009
DK12.08.2009
FI12.08.2009
NL12.08.2009
SE12.08.2009
TR12.08.2009
GR13.11.2009
IE07.12.2009
LU07.12.2009
PT12.12.2009
CH31.12.2009
LI31.12.2009
[2011/44]
Former [2011/21]AT12.08.2009
DK12.08.2009
FI12.08.2009
NL12.08.2009
SE12.08.2009
GR13.11.2009
IE07.12.2009
LU07.12.2009
PT12.12.2009
CH31.12.2009
LI31.12.2009
Former [2010/49]AT12.08.2009
DK12.08.2009
FI12.08.2009
NL12.08.2009
SE12.08.2009
GR13.11.2009
IE07.12.2009
PT12.12.2009
CH31.12.2009
LI31.12.2009
Former [2010/46]AT12.08.2009
DK12.08.2009
FI12.08.2009
NL12.08.2009
SE12.08.2009
GR13.11.2009
IE07.12.2009
PT12.12.2009
Former [2010/20]AT12.08.2009
DK12.08.2009
FI12.08.2009
NL12.08.2009
SE12.08.2009
PT12.12.2009
Former [2010/17]AT12.08.2009
FI12.08.2009
NL12.08.2009
SE12.08.2009
PT12.12.2009
Former [2010/10]AT12.08.2009
FI12.08.2009
NL12.08.2009
SE12.08.2009
Former [2010/09]AT12.08.2009
FI12.08.2009
SE12.08.2009
Former [2010/08]AT12.08.2009
SE12.08.2009
Documents cited:Search[DA]EP0747355  (YAMANOUCHI PHARMA CO LTD [JP]) [DA] 1-3 * page 11 * * page 46; examples 11,13 *;
 [A]  - NAITO R ET AL, "Selective Muscarinic Antagonists. I. Synthesis and Antimuscarinic Properties of 4-Piperidyl Benzhydrylcarbamate Derivatives", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN. TOKYO, JP, (199808), vol. 46, no. 8, ISSN 0009-2363, pages 1274 - 1285, XP002127947 [A] 1-3 * chart 1* * example 9 * * table 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.